Results 121 to 130 of about 4,960 (145)

[Use of psychotropic drugs among Indigenous and Quilombola communities in Brazil]. [PDF]

Salud Colect
Loures GDSG, Ronzani TM, Paula PAB, Dimenstein M, Fernandes SL, Leite JF, Macedo JPS, Silva GM.   +7 more
europepmc   +1 more source

[Comparison of quality of life in patients living with HIV infection through pharmaceutical care according to CMO methodology vs. conventional follow-up. MAS-VIH project]. [PDF]

Rev Esp Quimioter
Martínez Sesmero JM, Margusino Framiñan L, Gimeno Gracia M, Áreas Del Águila V, Navarro Aznares H, Huertas Fernández MJ, Molina Cuadrado E, Díaz Ruiz P, Martin Conde MT, Alonso Grandes E, Lázaro López A, Morillo Verdugo R.   +11 more
europepmc   +1 more source

[Design of a Tool for Patient Classification Based on Pharmacotherapeutic Attitudes]. [PDF]

Farm Comunitarios
Reyes Estévez D, Charola Ramos L, Horas Barrera C, Mencias Hurtado AB, Arranz Durán J, Martínez Carretero E.   +5 more
europepmc   +1 more source

[Initial descriptive study on Pharmaceutical Indication in community pharmacies in Central American countries]. [PDF]

Farm Comunitarios
Badilla-Baltodano B, Orellana K, Martínez-Martínez F, Martínez de Haase L, Monge-Bogantes LC, Liere-Godoy AM.   +5 more
europepmc   +1 more source

[Effectiveness of an intervention strategy in the biosimilar glargine prescription pattern in primary care]. [PDF]

Aten Primaria, 2019
Saborido-Cansino C, Santos-Ramos B, Carmona-Saucedo C, Rodríguez-Romero MV, González-Martín A, Palma-Amaro A, Rojas-Lucena IM, Almeida-González C, Sánchez-Fidalgo S.   +8 more
europepmc   +1 more source

Atención farmacéutica al paciente con insusficiencia renal crónica: seguimiento farmacoterapéutico y farmacogenética

, 2011
Clarice Chemello
openalex   +1 more source

Impacto del seguimiento farmacoterapéutico en la calidad de vida relacionada a la salud de pacientes con hipertension arterial

, 2010
Liana K. Ayala L, Kelya Condezo M, José R. Juárez E   +2 more
openalex   +2 more sources

Medicines withdrawn in other countries due to safety problems, between 2014 and 2023, and their permanence in the Argentine market. [PDF]

Rev Fac Cien Med Univ Nac Cordoba
Caffaratti M, Cañás M, Domosbian DE, Giraudo E, González AM, Lorenzo A, Núñez Montoya S, Rocha MT, Traverso ML, Uema S.   +9 more
europepmc   +1 more source